Article Dans Une Revue Veterinary Research Année : 2026

Paclitaxel induces trained immunity via the GPR183–STING axis to enhance host defense against MRSA infection

Cheng-Kai Zhou
  • Fonction : Auteur
Jia-Bao Zhang
  • Fonction : Auteur
Yong-Jun Yang
  • Fonction : Auteur
Wei Chen
  • Fonction : Auteur
Zhen-Zhen Liu
  • Fonction : Auteur correspondant
  • PersonId : 1646906

Connectez-vous pour contacter l'auteur

Résumé

AbstractMethicillin-resistant Staphylococcus aureus (MRSA) remains a major global health threat with limited prophylactic options. Trained immunity, characterized by nonspecific functional reprogramming of innate immune cells, offers a promising strategy for infection control. Here, we identify paclitaxel (PTX), a microtubule-stabilizing agent widely used in cancer therapy, as a novel inducer of trained immunity in macrophages. Unlike the microtubule-destabilizing agent nocodazole (Noco), PTX enhanced macrophage proinflammatory responses, phagocytosis, and bacterial killing upon secondary stimulation. Mechanistically, PTX-induced training activated the stimulator of interferon genes protein (STING) pathway, evidenced by increased phosphorylation of STING, TBK1, and IRF3. STING deficiency abolished the trained immune responses and antimicrobial functions. PTX also triggered metabolic reprogramming toward aerobic glycolysis via the Akt–mTOR–HIF1α pathway, which was essential for the trained phenotype. Transcriptomic and functional analyses further revealed that the GPR183–STING axis mediated PTX-induced trained immunity. Inhibition of GPR183 impaired STING activation and suppressed functional responses in vitro. In a murine MRSA pneumonia model, PTX-trained mice showed reduced bacterial burden, preserved lung barrier integrity, and enhanced immune activation, all of which were reversed by GPR183 inhibition or STING deficiency. Collectively, our findings uncover a previously unrecognized immunomodulatory function of PTX and highlight the therapeutic potential of targeting the GPR183–STING axis to enhance trained immunity against resistant bacterial infections.Graphical Abstract

Fichier principal
Vignette du fichier
13567_2025_Article_1704.pdf (9.77 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

hal-05511861 , version 1 (16-02-2026)

Licence

Identifiants

Citer

Cheng-Kai Zhou, Jia-Bao Zhang, Yong-Jun Yang, Wei Chen, Zhen-Zhen Liu. Paclitaxel induces trained immunity via the GPR183–STING axis to enhance host defense against MRSA infection. Veterinary Research, 2026, 57 (1), pp.30. ⟨10.1186/s13567-025-01704-8⟩. ⟨hal-05511861⟩

Collections

62 Consultations
38 Téléchargements

Altmetric

Partager

  • More